MedPath

clinical study of the autologous oral mucosal epithelial cell sheets in preventing formation of strictures after endoscopic submucosal dissection for esophageal cancer

Phase 1
Recruiting
Conditions
Case with esophageal stricture following ESD treatment for early esophageal cancer
Registration Number
JPRN-UMIN000026506
Lead Sponsor
Tomishiro Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with complications of poor control (Heart disease, liver disease, kidney disease, cerebral infarction, etc.). 2)Patients with pregnancy, lactating women and possibility (intention) of pregnancy. 3)A patient with a history of serious drug allergy. 4)Patients infected with infectious diseases (hepatitis B, hepatitis C, HIV, HTLV-1, syphilis). 5)A patient who has a disease in the oral mucosa at the tissue collection site and is unable to collect it. 6)Other patients who are deemed inappropriate by the research representative.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety of Oral Mucosal Epithelial Cell Sheet
Secondary Outcome Measures
NameTimeMethod
Preventive effect of esophageal narrowing by oral mucosal epithelial cell sheet transplantation
© Copyright 2025. All Rights Reserved by MedPath